I
INFevo
China · Biotech · AI
Develops virtual-cell AI models and automated experimental workflows for biological research.
Product
INFevo develops AI models that predict how cells respond to drugs, genetic changes and other interventions. Its OCOO models work alongside automated cell experiments, allowing laboratory results to feed back into subsequent predictions.
Incubated by XtalPi, the company also develops Karl Workbench, a biological-research workspace for analysing data and testing scientific hypotheses. The platform is in beta and connects research questions, analyses and evidence across successive experiments.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-A | >CN¥100M | DT Capital Partners — ParticipantHongShan — ParticipantHuagai Capital — ParticipantHuakong Fund — ParticipantLINK-X CAPITAL — ParticipantProsperity7 — ParticipantShunwei Capital — Participant |